BCCI Mission
The mission of Yonsei University BCCI is to drive a paradigm shift in the understanding of aging and multimorbidity in order to extend healthy human life span.
To achieve this mission, BCCI has established a Yonsei Research Complex that brings together researchers from ten colleges—including Medicine, Dentistry, Life Sciences, Pharmacy, Engineering, Natural Sciences, Quantum Information Science, and Artificial Intelligence—into a one-roof convergence research ecosystem.
Leveraging Yonsei–IBM Quantum Computing, state-of-the-art research infrastructure, Yonsei Digital Healthcare clinical data, biomedical research institutes, university hospitals, and an integrated bio-cluster connecting academia, hospitals, and industry, BCCI conducts deeply integrated research on aging and age-associated multimorbidity.
Through this convergence approach, BCCI aims to:
- Elucidate the biological mechanisms linking aging and multiple chronic diseases
- Redefine aging not as isolated diseases but as a systemic, interconnected process
- Develop innovative diagnostic, preventive, and therapeutic strategies
- Establish a new scientific framework that transforms the aging–multimorbidity paradigm
Ultimately, BCCI seeks to become a global hub for convergence research that reshapes how aging and complex diseases are understood, prevented, and treated, contributing to longer, healthier lives for humanity.
BCCI Value
Advancing Healthy Life Span for Humanity
BCCI is committed to addressing one of the most critical challenges of humankind in the 21st century: extending healthy life span alongside increasing life expectancy. We believe that improving health, not merely prolonging life, is fundamental to human dignity and societal sustainability.
Convergence Science Beyond Disciplinary Boundaries
BCCI values deep interdisciplinary collaboration as the key to understanding aging and age-related multimorbidity. By integrating medicine, dentistry, life sciences, pharmacy, engineering, natural sciences, quantum information science, and artificial intelligence, we pursue solutions that no single discipline can achieve alone.
Data-Driven and Technology-Enabled Innovation
We embrace cutting-edge technologies—including quantum computing, artificial intelligence, digital healthcare platforms, and large-scale clinical data—to uncover complex biological mechanisms underlying aging and multiple chronic diseases.
Translational Impact from Discovery to Society
BCCI values research that bridges fundamental science and real-world impact, transforming scientific discoveries into clinical, industrial, and societal solutions through strong hospital–industry–research integration.
Yonsei University’s research
capabilities optimized for Medicine 3.0
A paradigm shift toward multi-disease and aging research through BCCI-based, one-roof convergent research linking industry, academia, research institutes, and hospitals.
01
Competency 1
Possession of outstanding, unrivaled research groups
Research groups leading the field of life sciences *QS World University Ranking Ranked 50th (No. 1 among private universities in Asia for four consecutive years)
Medicine, Dentistry, Life Sciences, Pharmacy, Engineering, Department of Quantum Information Science, College of AI Convergence, College of Science, IBS
> Formation of interdisciplinary research groups
02
Competency 2
BCCI-centered Yonsei Research Complex
College of Life Systems, College of Engineering, and College of Medicine Complex
One-Roof Innovation : Appropriateness of site selection for the One-Roof Convergent Research Building for the BCCI-centered Yonsei Research Complex
> A landmark for one-roof convergent research
03
Competency 3
Research-focused hospitals and advanced infrastructure
- Yonsei–IBM Quantum Computing Center : The world’s fifth, and the first in Korea
- Yonsei University Core facilities : Housing shared research equipment valued at KRW 23 billion in total.
- Yonsei Digital Health Center : 9 million+ alpha patient database (2.0 petabytes)
- Yonsei Institute for Biomedical Research : Research-oriented hospital
- Yonsei–Severance Heavy Ion Center : The first in Korea
- Bio cluster hub : A comprehensive bio cluster linking industry, academia, institutes, and hospitals
- Institute for Basic Science (IBS) : Human-Machine Interface
Research groups in BCCI
The establishment process of BCCI
-
Finalization of an NRL-based research complex for aging, intractable cancer, and advanced new drug development
-
2025.07
Board approval for the establishment of the Convergence Research Building (Bio-Y / One-Roof Innovation)
-
2025.04
Board approval for the establishment of the Convergence Research Building (Bio-Y / One-Roof Innovation)
-
2025.03
- Formation of the BIO-Y Establishment Promotion Committee
- Opening of the Yonsei Quantum Complex
-
2023.03
Establishment of the Graduate School of Biomedical Convergence (participation of 60 full-time faculty members from 10 departments)
-
2021.11
Establishment of Yonsei Biohealth Technology Holding Company
-
2021.03
Yonsei Signature Research Cluster Project (Project Y Convergence Initiative)
-
2014.04
Board approval of the master plan for the biomedical science complex (One Roof convergence project)
-
2011.05
Establishment of Yonsei University’s Technology Holding Company
-
2011.03
Establishment of the Institute of Life Systems / Avison / College of Pharmacy
-
2010.03
Establishment of the Life Science and Engineering and Bio-Convergence majors (establishment of the Songdo International Campus)
-
2008.03
Establishment of an independent College of Life Science and Biotechnology
-
Building upon a 140-year legacy that began with Jejungwon and Yonhi College in 1885, BCCI serves as an innovative bridge to design the next 100 years of bio research.